pyridoxine has been researched along with Cardiovascular Diseases in 47 studies
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Epidemiological and laboratory studies suggest that increasing concentrations of plasma homocysteine (total homocysteine [tHcy]) accelerate cardiovascular disease by promoting vascular inflammation, endothelial dysfunction, and hypercoagulability." | 9.11 | Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy o ( Baker, R; Dusitanond, P; Eikelboom, JW; Gilmore, G; Hankey, GJ; Jamrozik, K; Klijn, CJ; Langton, P; Loh, K; Thom, J; van Bockxmeer, FM; Yi, Q, 2005) |
| "Hyperhomocysteinemia is a cardiovascular disease (CVD) risk factor." | 7.71 | Influence of vitamin-optimized plasma homocysteine cutoff values on the prevalence of hyperhomocysteinemia in healthy adults. ( Dijck-Brouwer, DA; Fokkema, MR; Muskiet, FA; van Doormaal, JJ; Weijer, JM, 2001) |
| "Pyridoxine, vitamin B6, is a cofactor for cystathionine beta synthase, which mediates the transformation of homocysteine to cystathionine, the initial step in the transsulfuration pathway and the urinary excretion of sulfur." | 6.40 | B vitamins and homocysteine in cardiovascular disease and aging. ( Wilcken, B; Wilcken, DE, 1998) |
| "Epidemiological and laboratory studies suggest that increasing concentrations of plasma homocysteine (total homocysteine [tHcy]) accelerate cardiovascular disease by promoting vascular inflammation, endothelial dysfunction, and hypercoagulability." | 5.11 | Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy o ( Baker, R; Dusitanond, P; Eikelboom, JW; Gilmore, G; Hankey, GJ; Jamrozik, K; Klijn, CJ; Langton, P; Loh, K; Thom, J; van Bockxmeer, FM; Yi, Q, 2005) |
| " In this article we review the main theories of atherosclerosis which take into account the proteins, namely homocysteine, homocysteine metabolism, the cause that may be responsible for high levels of homocysteinemia, the pathophysiologic mechanisms of vascular lesion induced by hyperhomocysteinemia, the clinical evidence that homocysteinemia constitutes a vascular risk factor and finally, the evidence that it is possible to control homocysteinemia with supplementation of co-factors of homocysteine metabolism, namely vitamin B6, B12 or folic acid." | 4.80 | [Homocysteinemia and vascular disease--a new risk factor is born]. ( Luís, AS; Reis, RP, 1999) |
| "Hyperhomocysteinemia refers to an elevated circulating level of the sulfur-containing amino acid homocysteine and has been shown to be a risk factor for vascular disease in the general population." | 4.80 | Homocysteine and renal disease. ( Robinson, K; van Guldener, C, 2000) |
| "Hyperhomocysteinemia is a cardiovascular disease (CVD) risk factor." | 3.71 | Influence of vitamin-optimized plasma homocysteine cutoff values on the prevalence of hyperhomocysteinemia in healthy adults. ( Dijck-Brouwer, DA; Fokkema, MR; Muskiet, FA; van Doormaal, JJ; Weijer, JM, 2001) |
| "In study II, 41 patients with type 2 diabetes and mild hyperhomocysteinaemia were analysed after 6 months treatment with 5 mg of folic acid or placebo." | 2.72 | No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk. ( Brouwer, CB; Rauwerda, JA; Smulders, YM; Spoelstra-de Man, AM; Stehouwer, CD; Teerlink, T, 2006) |
| "Chlorogenic acid is a major polyphenol in coffee; coffee drinkers consume up to 1 g chlorogenic acid/d." | 2.70 | Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans. ( Hollman, PC; Katan, MB; Olthof, MR; Zock, PL, 2001) |
| "Pyridoxine, vitamin B6, is a cofactor for cystathionine beta synthase, which mediates the transformation of homocysteine to cystathionine, the initial step in the transsulfuration pathway and the urinary excretion of sulfur." | 2.40 | B vitamins and homocysteine in cardiovascular disease and aging. ( Wilcken, B; Wilcken, DE, 1998) |
| "Homocystinuria is an uncommon genetic disease characterized by a marked increase of serum homocysteine (HCY), an intermediate of methionine metabolism." | 2.40 | [Homocysteine and cardiovascular risk]. ( Chapelle, JP; Gielen, J; Lutteri, L, 1999) |
| " This review summarises that available pharmacokinetic data involving levodopa, especially as it relates to therapeutic response of parkinsonian patients." | 2.35 | Clinical pharmacokinetics of levodopa in parkinson's disease. ( Bianchine, JR; Shaw, GM, 1976) |
| " We also performed the dosage of plasma levels of B6 and B12 vitamins and of red cells folates." | 1.31 | [Influence of smoking on homocysteinemia at baseline and after methionine load]. ( Azinheira, J; Correia, JM; Luís, AS; Pina, JE; Reis, HP; Reis, RP, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (10.64) | 18.7374 |
| 1990's | 21 (44.68) | 18.2507 |
| 2000's | 19 (40.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (4.26) | 2.80 |
| Authors | Studies |
|---|---|
| Bo, Y | 1 |
| Xu, H | 1 |
| Zhang, H | 1 |
| Zhang, J | 1 |
| Wan, Z | 1 |
| Zhao, X | 1 |
| Yu, Z | 1 |
| Zhang, N | 1 |
| Li, Z | 1 |
| Wu, Q | 1 |
| Huang, H | 1 |
| Wang, S | 1 |
| Liu, Y | 2 |
| Chen, J | 1 |
| Ma, J | 1 |
| Christen, WG | 1 |
| Glynn, RJ | 1 |
| Chew, EY | 1 |
| Albert, CM | 1 |
| Manson, JE | 1 |
| Wu, Y | 1 |
| Han, Y | 1 |
| Cui, B | 1 |
| Mi, Q | 1 |
| Huang, Y | 1 |
| Wang, L | 1 |
| Jiang, Q | 1 |
| Chen, Q | 1 |
| Liu, N | 1 |
| Ferro, A | 1 |
| Ji, Y | 1 |
| Dusitanond, P | 1 |
| Eikelboom, JW | 1 |
| Hankey, GJ | 1 |
| Thom, J | 1 |
| Gilmore, G | 1 |
| Loh, K | 1 |
| Yi, Q | 2 |
| Klijn, CJ | 1 |
| Langton, P | 1 |
| van Bockxmeer, FM | 1 |
| Baker, R | 1 |
| Jamrozik, K | 1 |
| Spoelstra-de Man, AM | 1 |
| Teerlink, T | 1 |
| Brouwer, CB | 1 |
| Rauwerda, JA | 2 |
| Stehouwer, CD | 2 |
| Smulders, YM | 1 |
| Sawka, AM | 1 |
| Ray, JG | 1 |
| Josse, RG | 1 |
| Lonn, E | 1 |
| Nexo, E | 1 |
| Ubbink, JB | 1 |
| Vermaak, WJ | 1 |
| van der Merwe, A | 1 |
| Becker, PJ | 1 |
| Stampfer, MJ | 2 |
| Bostom, AG | 1 |
| Shemin, D | 1 |
| Verhoef, P | 1 |
| Nadeau, MR | 1 |
| Jacques, PF | 1 |
| Selhub, J | 1 |
| Dworkin, L | 1 |
| Rosenberg, IH | 1 |
| McCully, KS | 1 |
| Blann, AD | 1 |
| Lip, GY | 1 |
| Tamura, T | 1 |
| Bergman, SM | 1 |
| Morgan, SL | 1 |
| Kuller, LH | 1 |
| Evans, RW | 1 |
| Winocour, PH | 1 |
| Clarke, R | 1 |
| Collins, R | 1 |
| Wilcken, DE | 2 |
| Wilcken, B | 2 |
| Osganian, SK | 1 |
| Spiegelman, D | 1 |
| Rimm, E | 1 |
| Cutler, JA | 1 |
| Feldman, HA | 1 |
| Montgomery, DH | 1 |
| Webber, LS | 1 |
| Lytle, LA | 1 |
| Bausserman, L | 1 |
| Nader, PR | 1 |
| Genest, J | 1 |
| Reis, RP | 2 |
| Luís, AS | 2 |
| van den Berg, H | 1 |
| Lutteri, L | 1 |
| Chapelle, JP | 1 |
| Gielen, J | 1 |
| de Jong, SC | 1 |
| van den Berg, M | 1 |
| Geurts, TW | 1 |
| Bouter, LM | 1 |
| Chait, A | 1 |
| Malinow, MR | 1 |
| Nevin, DN | 1 |
| Morris, CD | 1 |
| Eastgard, RL | 1 |
| Kris-Etherton, P | 1 |
| Pi-Sunyer, FX | 1 |
| Oparil, S | 1 |
| Resnick, LM | 1 |
| Stern, JS | 1 |
| Haynes, RB | 1 |
| Hatton, DC | 1 |
| Metz, JA | 1 |
| Clark, S | 1 |
| McMahon, M | 1 |
| Holcomb, S | 1 |
| Reusser, ME | 1 |
| Snyder, GW | 1 |
| McCarron, DA | 1 |
| Meleady, R | 1 |
| Graham, I | 1 |
| Azinheira, J | 1 |
| Reis, HP | 1 |
| Pina, JE | 1 |
| Correia, JM | 1 |
| Bleich, S | 1 |
| Degner, D | 1 |
| Kropp, S | 1 |
| Rüther, E | 1 |
| Kornhuber, J | 1 |
| van Guldener, C | 1 |
| Robinson, K | 1 |
| Sunder-Plassmann, G | 1 |
| Winkelmayer, WC | 1 |
| Födinger, M | 1 |
| Scherer, CS | 1 |
| Baker, DH | 1 |
| Kok, FJ | 2 |
| Pietrzik, K | 1 |
| Olthof, MR | 1 |
| Hollman, PC | 1 |
| Zock, PL | 1 |
| Katan, MB | 1 |
| Raslová, K | 1 |
| Bederová, A | 1 |
| Gasparovic, J | 1 |
| Blazícek, P | 1 |
| Smolková, B | 1 |
| Monge-Rojas, R | 1 |
| Fokkema, MR | 1 |
| Weijer, JM | 1 |
| Dijck-Brouwer, DA | 1 |
| van Doormaal, JJ | 1 |
| Muskiet, FA | 1 |
| Wrone, EM | 1 |
| Zehnder, JL | 1 |
| Hornberger, JM | 1 |
| McCann, LM | 1 |
| Coplon, NS | 1 |
| Fortmann, SP | 1 |
| Yap, S | 1 |
| Boers, GH | 1 |
| Brenton, DP | 1 |
| Lee, PJ | 1 |
| Walter, JH | 1 |
| Howard, PM | 1 |
| Naughten, ER | 1 |
| Bianchine, JR | 1 |
| Shaw, GM | 1 |
| Van Poppel, G | 1 |
| Schneijder, P | 1 |
| Löwik, MR | 1 |
| Schrijver, J | 1 |
| Giard, P | 1 |
| Leuridan, B | 1 |
| Dutoit, A | 1 |
| Carson, NA | 1 |
| Chiti, E | 1 |
| Guidetti, E | 1 |
| Strada, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)[NCT00000541] | Phase 2 | 0 participants | Interventional | 1993-05-31 | Completed | ||
| [NCT00000161] | Phase 3 | 0 participants | Interventional | 1993-08-31 | Active, not recruiting | ||
| HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)[NCT00106886] | Phase 4 | 5,000 participants | Interventional | 1999-12-31 | Active, not recruiting | ||
| [NCT00000467] | Phase 3 | 0 participants | Interventional | 1987-09-30 | Completed | ||
| Efficacy Study of Folic Acid Supplementation on Homocysteine Levels in Adolescent Epileptics Taking Antiepileptic Drugs: A Single Blind Randomized Controlled Clinical Trial[NCT02318446] | Phase 3 | 36 participants (Anticipated) | Interventional | 2015-03-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for pyridoxine and Cardiovascular Diseases
| Article | Year |
|---|---|
Hyperhomocysteinemia as a cause of vascular occlusion in end-stage-renal disease.
Topics: Cardiovascular Diseases; Dietary Supplements; Folic Acid; Folic Acid Deficiency; Hematinics; Homocys | 1998 |
Homocysteine, vitamins, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Homocysteine; Humans; Pyridoxine; Vitamin B 12 | 1998 |
Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
Topics: Cardiovascular Diseases; Dietary Supplements; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia | 1998 |
B vitamins and homocysteine in cardiovascular disease and aging.
Topics: Aging; Cardiovascular Diseases; Diet; Folic Acid; Folic Acid Deficiency; Homocysteine; Homocystinuri | 1998 |
[Homocysteinemia and vascular disease--a new risk factor is born].
Topics: Arteriosclerosis; Cardiovascular Diseases; Folic Acid; Humans; Hyperhomocysteinemia; Pyridoxine; Ris | 1999 |
[Homocysteine and cardiovascular risk].
Topics: Arteriosclerosis; Cardiovascular Diseases; Folic Acid; Homocystinuria; Humans; Hyperhomocysteinemia; | 1999 |
Plasma homocysteine as a cardiovascular risk factor: causal, consequential, or of no consequence?
Topics: Aged; Cardiovascular Diseases; Case-Control Studies; Cross-Sectional Studies; Female; Folic Acid; Fo | 1999 |
Homocysteine and renal disease.
Topics: Adult; Arteriosclerosis; Cardiovascular Diseases; Case-Control Studies; Child; Endothelium, Vascular | 2000 |
Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Clinical Trials as Topic; Folic Acid; Homocysteine; Humans; Hyperh | 2000 |
Folic acid, vitamins B6 and B12: relation to homocysteine and cardiovascular disease.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Pyridoxine; Risk Factors; Vitamin B 12 | 2001 |
Rationale for risk reduction of cardiovascular disease using homocysteine concentration in blood and plasma as biomarker: support by clinical data.
Topics: Biomarkers; Cardiovascular Diseases; Dietary Supplements; Folic Acid; Homocysteine; Humans; Nutritio | 2001 |
Clinical pharmacokinetics of levodopa in parkinson's disease.
Topics: Carboxy-Lyases; Cardiovascular Diseases; Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Dru | 1976 |
10 trials available for pyridoxine and Cardiovascular Diseases
| Article | Year |
|---|---|
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.
Topics: Adult; Aged; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Endpoint Deter | 2009 |
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.
Topics: Adult; Aged; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Endpoint Deter | 2009 |
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.
Topics: Adult; Aged; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Endpoint Deter | 2009 |
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.
Topics: Adult; Aged; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Endpoint Deter | 2009 |
Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy o
Topics: Biomarkers; Blood Coagulation; Cardiovascular Diseases; Endothelium, Vascular; Folic Acid; Homocyste | 2005 |
No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk.
Topics: Adolescent; Adult; Arginine; Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Do | 2006 |
Randomized clinical trial of homocysteine level lowering therapy and fractures.
Topics: Aged; Cardiovascular Diseases; Drug Therapy, Combination; Female; Folic Acid; Fractures, Bone; Homoc | 2007 |
Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia.
Topics: Adult; Aged; Cardiovascular Diseases; Cystathionine beta-Synthase; Dose-Response Relationship, Drug; | 1993 |
Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease.
Topics: Adult; Aged; Analysis of Variance; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet; Female; | 1999 |
Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans.
Topics: Adult; Cardiovascular Diseases; Chlorogenic Acid; Coffee; Cross-Over Studies; Fasting; Female; Flavo | 2001 |
An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease.
Topics: Body Mass Index; Cardiovascular Diseases; Cross-Sectional Studies; Ethnicity; Female; Folic Acid; Ge | 2001 |
Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study.
Topics: Adolescent; Adult; Aged; Betaine; Cardiovascular Diseases; Child; Child, Preschool; Comorbidity; Dru | 2001 |
[Clinical trial of pyridoxilate: oral and injectable forms].
Topics: Aged; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Pyridoxine | 1969 |
25 other studies available for pyridoxine and Cardiovascular Diseases
| Article | Year |
|---|---|
Intakes of Folate, Vitamin B6, and Vitamin B12 in Relation to All-Cause and Cause-Specific Mortality: A National Population-Based Cohort.
Topics: Adult; Cardiovascular Diseases; Cause of Death; Female; Folic Acid; Humans; Male; Nutrition Surveys; | 2022 |
Associations of Dietary Zinc-Vitamin B6 Ratio with All-Cause Mortality and Cardiovascular Disease Mortality Based on National Health and Nutrition Examination Survey 1999-2016.
Topics: Cardiovascular Diseases; Diet; Humans; Nutrition Surveys; Prospective Studies; Pyridoxine; Vitamin B | 2023 |
Pyridoxine increases nitric oxide biosynthesis in human platelets.
Topics: Adenosine Diphosphate; Adult; Blood Platelets; Cardiovascular Diseases; Cyclic GMP; Dose-Response Re | 2009 |
[Vitamins against cardiovascular diseases?].
Topics: Cardiovascular Diseases; Humans; Pyridoxine; Vitamin B 12 | 1994 |
Homocysteine levels and cardiovascular disease.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Pyridoxine; Vitamin B 12; Vitamins | 1997 |
Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study.
Topics: Adult; Aged; Arteriosclerosis; Blood Glucose; Cardiovascular Diseases; Cholesterol, HDL; Cohort Stud | 1997 |
Homocysteine, folate, vitamin B6, and cardiovascular disease.
Topics: Animals; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Nutritional Status; Pyridoxine; | 1998 |
Hyperhomocysteinaemia: a cardiovascular risk factor needing a large intervention trial?
Topics: Blood Coagulation Factors; Cardiovascular Diseases; Clinical Trials as Topic; Diet; Endothelium, Vas | 1997 |
Nutrition and therapeutics.
Topics: Cardiovascular Diseases; Diet Therapy; Female; Folic Acid; Homocysteine; Humans; Male; Nutritional S | 1998 |
Do you need this heart disease test?
Topics: Cardiovascular Diseases; Folic Acid; Heart Diseases; Humans; Hyperhomocysteinemia; Nutrition Policy; | 1999 |
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascular Health.
Topics: Adolescent; Cardiovascular Diseases; Cross-Sectional Studies; Female; Folic Acid; Health Surveys; Ho | 1999 |
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascular Health.
Topics: Adolescent; Cardiovascular Diseases; Cross-Sectional Studies; Female; Folic Acid; Health Surveys; Ho | 1999 |
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascular Health.
Topics: Adolescent; Cardiovascular Diseases; Cross-Sectional Studies; Female; Folic Acid; Health Surveys; Ho | 1999 |
Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascular Health.
Topics: Adolescent; Cardiovascular Diseases; Cross-Sectional Studies; Female; Folic Acid; Health Surveys; Ho | 1999 |
Hyperhomocyst(e)inemia--determining factors and treatment.
Topics: Animals; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Cricetinae; Female; F | 1999 |
Vitamin B6 status and requirements in older adults.
Topics: Aged; Cardiovascular Diseases; Female; Homocysteine; Humans; Liver; Male; Nutritional Requirements; | 1999 |
Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study.
Topics: Adult; Age of Onset; Aged; Arterial Occlusive Diseases; Cardiovascular Diseases; Female; Folic Acid; | 1999 |
[Influence of smoking on homocysteinemia at baseline and after methionine load].
Topics: Adult; Cardiovascular Diseases; Female; Homocysteine; Humans; Male; Methionine; Pyridoxine; Risk Fac | 2000 |
Red wine, spirits, beer and serum homocysteine.
Topics: Alcohol Drinking; Alcoholic Beverages; Alcoholism; Beer; Cardiovascular Diseases; Homocysteine; Huma | 2000 |
Excess dietary methionine markedly increases the vitamin B-6 requirement of young chicks.
Topics: Animals; Cardiovascular Diseases; Chickens; Dietary Proteins; Growth; Homocysteine; Methionine; Mode | 2000 |
Effect of diet and 677 C-->T 5, 10-methylenetetrahydrofolate reductase genotypes on plasma homocyst(e)ine concentrations in slovak adolescent population.
Topics: Adolescent; Cardiovascular Diseases; Child; Cholesterol, Dietary; Diet; Dietary Carbohydrates; Dieta | 2000 |
Dietary intake as a cardiovascular risk factor in Costa Rican adolescents.
Topics: Adolescent; Adult; Analysis of Variance; Cardiovascular Diseases; Chi-Square Distribution; Cholester | 2001 |
Influence of vitamin-optimized plasma homocysteine cutoff values on the prevalence of hyperhomocysteinemia in healthy adults.
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Female; Folic Acid; Homocysteine; Humans; Hyperhom | 2001 |
A statement of homocyst(e)ine and cardiovascular disease.
Topics: Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Pyridoxine; Risk Factors; Vitamin B 12 | 2001 |
Nutritional status and food consumption in 10-11 year old Dutch boys (Dutch Nutrition Surveillance System).
Topics: Ascorbic Acid; Blood Pressure; Body Weight; Cardiovascular Diseases; Child; Cholesterol; Dietary Car | 1991 |
Homocystinuria.
Topics: Cardiovascular Diseases; Child; Child, Preschool; Diet Therapy; Eye Diseases; Folic Acid; Homocystin | 1970 |
[Use in cardiology of a preparation of 3 coenzymes].
Topics: Adult; Aged; Cardiovascular Diseases; Coenzymes; Humans; Male; Middle Aged; Pyridoxine; Thiamine; Vi | 1970 |
[Therapeutic effects of pyridoxilates in vascular diseases as a factor of saving of oxygen at cellular level].
Topics: Cardiovascular Diseases; Glyoxylates; Humans; Oxygen Consumption; Pyridoxine | 1968 |